Helen M Sheldrake
7PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jul 23, 2025
K562 Chronic Myeloid Leukemia Cells as a Dual β3-Expressing Functional Cell Line Model to Investigate the Effects of Combined αIIbβ3 and αvβ3 Antagonism.Amal A Elsharif, Laurence H Patterson, Steven D Shnyder
|Apr 29, 2025
Antioxidant, Anti-Inflammatory, and Oral Bioavailability of Novel Sulfonamide Derivatives of Gallic Acid.Dania Alhyari, Nidal A Qinna, Helen M Sheldrake
|Sep 16, 2024
Sidechain structure-activity relationships of cyclobutane-based small molecule αvβ3 antagonists.Adam Throup, Manar Saleh Zraikat, Andrew Gordon
|Jul 27, 2024
Overcoming Vemurafenib Resistance in Metastatic Melanoma: Targeting Integrins to Improve Treatment Efficacy.Asiye Busra Boz Er, Helen M Sheldrake, Mark Sutherland
|Aug 26, 2023
Synthesis and Biological Evaluation of Cyclobutane-Based β3 Integrin Antagonists: A Novel Approach to Targeting Integrins for Cancer Therapy.Mark Sutherland, Andrew Gordon, Fatemah O F O Al-Shammari
|Nov 02, 2019
Exploration of [2 + 2 + 2] cyclotrimerisation methodology to prepare tetrahydroisoquinoline-based compounds with potential aldo-keto reductase 1C3 target affinity.Ana R N Santos, Helen M Sheldrake, Ali I M Ibrahim
Pageof 2
Frequent Collaborators
2 joint publications
Mark Sutherland
2 joint publications
Steven D Shnyder
1 joint publications
Davide Bonanni
1 joint publications
Donatella Boschi
1 joint publications
Marco L Lolli
1 joint publications
Klaus Pors
1 joint publications
Fatemah O F O Al-Shammari
1 joint publications
Nidal A Qinna
1 joint publications
Sriharsha Kantamneni
